Aging Clinical and Experimental Research

, Volume 16, Issue 3, pp 244–248 | Cite as

Association between longevity and cytokine gene polymorphisms. A study in Sardinian centenarians

  • Giovanni Mario Pes
  • Domenico Lio
  • Ciriaco Carru
  • Luca Deiana
  • Giovannella Baggio
  • Claudio Franceschi
  • Luigi Ferrucci
  • Fabiola Oliveri
  • Letizia Scola
  • Antonio Crivello
  • Giuseppina Candore
  • Giuseppina Colonna-Romano
  • Calogero Caruso
Thematic Section: Inflammation and Aging Original Article


Background and aims: Human longevity seems to be directly correlated with optimal functioning of the immune system, suggesting that some genetic determinants of longevity reside in those polymorphisms for the immune system genes which regulate immuneinflammatory responses, in particular cytokine gene polymorphisms. The frequency of − 174C single nucleotide polymorphism (SNP) in the promoter region of the interleukin(IL)-6 gene is increased in Italian male centenarians. Moreover, the frequency of − 1082G SNP at the 5′ flanking region of the IL-10 gene coding sequence is increased among male centenarians, and that of +874A SNP at the interferon (IFN)- γ gene was found more frequently in female centenarians. These findings indicate that different alleles at different cytokine gene codings for pro- (IL-6, IFN- γ) or anti-inflammatory (IL-10) cytokines may affect the individual life-span expectancy, influencing the type and intensity of immune-inflammatory responses against environmental stressors. Methods: In the present study, we analyzed these IL-6, IL-10 and IFN- γ gene polymorphisms in 112 (36 male, 76 female) centenarians from the island of Sardinia, whose population shows a genetic background quite different from that of mainland Italy, as well as in 137 sixty-year-old controls from the same geographic area. Results: No significant differences were observed on analyzing IL-6, IL-10 and IFN- γ polymorphism frequencies among centenarians and controls, either on the whole and when the data were analyzed according to gender. Conclusions: These data indicate that gene polymorphisms of cytokines playing a major regulatory role in the inflammatory response do not affect life expectancy in the Sardinian population. Thus, cytokine/longevity associations have a population-specific component, being affected by the population-specific gene pool as well as by gene-environment interactions, behaving as survival rather than longevity genes.

Key Words

Centenarians cytokines immunogenetics longevity polymorphisms 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Cournil A, Kirkwood TB. If you would live long, choose your parents well. Trends Genet 2001; 17: 233–5.PubMedCrossRefGoogle Scholar
  2. 2.
    Candore G, Colonna-Romano G, Lio D, Caruso C. Immunological and immunogenetic markers of successful and unsuccessful aging. Adv Cell Aging Gerontol 2003; 13: 29–45.CrossRefGoogle Scholar
  3. 3.
    Pawelec G, Barnett Y, Forsey R, et al. T cells and aging. 2002 update. Front Biosci 2002; 7: d1056–83.PubMedGoogle Scholar
  4. 4.
    Caruso C, Candore G, Cigna D, et al. Cytokine production pathway in the elderly. Immunol Res 1996; 15: 84–90.PubMedCrossRefGoogle Scholar
  5. 5.
    Ginaldi L, De Martinis M, D’Ostilio A, Marini L, Loreto MF, Quaglino D. Immunological changes in the elderly. Aging Clin Exp Res 1999; 11: 281–6.Google Scholar
  6. 6.
    Franceschi C, Bonafè M, Valensin S, et al. Inflamm-aging. An evolutionary perspective on immunosenescence. Ann N Y Acad Sci 2000; 908: 244–54.CrossRefGoogle Scholar
  7. 7.
    Pawelec G, Ouyang Q, Colonna-Romano G, Candore G, Lio D, Caruso C. Is human immunosenescence clinically relevant? Looking for immunological risk phenotypes. Trends Immunol 2002; 23: 330–2.PubMedCrossRefGoogle Scholar
  8. 8.
    Bonafe M, Olivieri F, Cavallone L, et al. A gender-dependent genetic predisposition to produce high levels of IL-6 is detrimental for longevity. Eur J Immunol 2001; 31: 2357–61.PubMedCrossRefGoogle Scholar
  9. 9.
    Lio D, Scola L, Crivello A, et al. Gender-specific association between −1082 IL-10 promoter polymorphism and longevity. Genes Immun 2002; 3: 30–3.PubMedCrossRefGoogle Scholar
  10. 10.
    Lio D, Scola L, Crivello A, et al. Inflammation, genetics, and longevity: further studies on the protective effects in men of IL-10 −1082 promoter SNP and its interaction with TNF-alpha −308 promoter SNP. J Med Genet 2003; 40: 296–9.PubMedCrossRefGoogle Scholar
  11. 11.
    Lio D, Scola L, Crivello A, et al. Allele frequencies of +874T→A single nucleotide polymorphism at the first intron of interferon-γ gene in a group of Italian centenarians. Exp Gerontol 2002; 37: 317–21.CrossRefGoogle Scholar
  12. 12.
    Deiana L, Ferrucci L, Pes GM, et al. AKEntAnnos. The Sardinia Study of Extreme Longevity. Aging Clin Exp Res 1999; 11: 142–9.Google Scholar
  13. 13.
    Franceschi C, Motta L, Valensin S, et al. Do men and women follow different trajectories to reach extreme longevity? Italian Multicenter Study on Centenarians. Aging Clin Exp Res 2000; 12: 77–84.Google Scholar
  14. 14.
    Wang XY, Hurme M, Jylha M, Hervonen A. Lack of association between human longevity and polymorphisms of IL-1 cluster, IL-6, IL-10 and TNF-alpha genes in Finnish nonagenarians. Mech Ageing Dev 2001; 123: 29–38.PubMedCrossRefGoogle Scholar
  15. 15.
    Ross OA, Curran MD, Meenagh A, et al. Study of age-association with cytokine gene polymorphisms in an aged Irish population. Mech Ageing Dev 2003; 124: 199–206.PubMedCrossRefGoogle Scholar
  16. 16.
    Rea IM, Ross OA, Armstrong M, et al. Interleukin-6-gene C/G 174 polymorphism in nonagenarian and octogenarian subjects in the BELFAST study. Reciprocal effects on IL-6, soluble IL-6 receptor and for IL-10 in serum and monocyte supernatants. Mech Ageing Dev 2003; 124: 555–61.Google Scholar
  17. 17.
    Lio D, Pes GM, Carru C, et al. Association between the HLA-DR alleles and longevity: a study in Sardinian population. Exp Gerontol 2003; 38: 313–7.PubMedCrossRefGoogle Scholar
  18. 18.
    Passarino G, Underhill PA, Cavalli-Sforza LL., et al. Y chromosome binary markers to study the high prevalence of males in Sardinian centenarians and the genetic structure of the Sardinian population. Hum Hered 2001; 52: 136–9.PubMedCrossRefGoogle Scholar
  19. 19.
    Vaupel JW. Trajectories of mortality at advanced age. In Watcher KW, Finch CE, Eds. The biodemography of longevity. Washington, DC: National Academy Press, 1997: pp 17–34.Google Scholar
  20. 20.
    Scola L, Licastro F, Chiappelli M, et al. Allele frequencies of +847T→A single nucleotide polymorphism at the first intron of IFN-γ gene in Alzheimer’s disease patients. Aging Clin Exp Res 2003; 15: 292–5.PubMedCrossRefGoogle Scholar
  21. 21.
    Bidwell J, Keen L, Gallagher G, et al. Cytokine gene polymorphism in human disease: on-line databases. Genes Immun 1999; 1: 3–19.PubMedCrossRefGoogle Scholar
  22. 22.
    Bruunsgaard H, Pedersen M, Pedersen BK. Aging and proinflammatory cytokines. Curr Opin Hematol 2001; 8, 131–6.PubMedCrossRefGoogle Scholar
  23. 23.
    Bidwell J, Keen L, Gallagher G, et al. Cytokine gene polymorphism in human disease: on-line databases (Suppl 1). Genes Immun 2001; 2: 61–70.PubMedCrossRefGoogle Scholar
  24. 24.
    Andreotti F, Porto I, Crea F, Maseri A. Inflammatory gene polymorphisms and ischaemic heart disease: review of population association studies. Heart 2002; 87: 107–12.PubMedCrossRefGoogle Scholar
  25. 25.
    Stephens JW, Humphries SE. The molecular genetics of cardiovascular disease: clinical implications. J Intern Med 2003; 253: 120–7.PubMedCrossRefGoogle Scholar
  26. 26.
    Ershler WB, Keller ET. Age-associated increased interleukin-6 gene expression, late-life diseases, and frailty. Annu Rev Med 2000; 51: 245–70.PubMedCrossRefGoogle Scholar
  27. 27.
    Ridker PM, Rifai N, Stampfer MJ, Hennekens CH. Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation 2000; 101: 1767–72.PubMedCrossRefGoogle Scholar
  28. 28.
    Fernandez-Real JM, Broch M, Vendrell J, et al. Interleukin-6 gene polymorphism and insulin sensitivity. Diabetes 2000; 49: 517–20.PubMedCrossRefGoogle Scholar
  29. 29.
    Yudkin JS, Kumari M, Humphries SE, Mohamed-Ali V. Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link? Atherosclerosis 2000; 148: 209–14.PubMedCrossRefGoogle Scholar
  30. 30.
    Rauramaa R, Vaisanen SB, Luong LA, et al. Stromelysin-1 and interleukin-6 gene promoter polymorphisms are determinants of asymptomatic carotid artery atherosclerosis. Arterioscler Thromb Vasc Biol 2000; 20: 2657–62.PubMedCrossRefGoogle Scholar
  31. 31.
    Vickers MA, Green FR, Terry C, et al. Genotype at a promoter polymorphism of the interleukin-6 gene is associated with baseline levels of plasma C-reactive protein. Cardiovasc Res 2002; 53: 1029–34.PubMedCrossRefGoogle Scholar
  32. 32.
    Moore KW, de Waal Malefyt R, Coffman RL, O’Garra A. Inter-leukin-10 and the interleukin-10 receptor. Annu Rev Immunol 2001; 19, 683–765.PubMedCrossRefGoogle Scholar
  33. 33.
    Smith DA, Irving SD, Sheldon J, Cole D, Kaski JC. Serum levels of the anti-inflammatory cytokine interleukin-10 are decreased in patients with unstable angina. Circulation 2001;104: 746–9.PubMedCrossRefGoogle Scholar
  34. 34.
    Donger C, Georges JL, Nicaud V, et al. New polymorphisms in the interleukin-10 gene—relationships to myocardial infarction. Eur J Clin Invest 2001; 31: 9–14.PubMedCrossRefGoogle Scholar
  35. 35.
    Koch W, Kastrati A, Bottiger C, Mehilli J, von Beckerath N, Schomig A. Interleukin-10 and tumor necrosis factor gene polymorphisms and risk of coronary artery disease and myocardial infarction. Atherosclerosis 2001; 159: 137–4.PubMedCrossRefGoogle Scholar
  36. 36.
    Girndt M, Kaul H, Sester U, et al. Anti-inflammatory inter-leukin-10 genotype protects dialysis patients from cardiovascular events. Kidney Int 2002; 62: 949–5.PubMedCrossRefGoogle Scholar
  37. 37.
    Lio D, Scola L, Crivello A, et al. IL-10 polymorphisms in patients affected by acute myocardial infarction. Genes Immun 2003; 4S1 (Abstract).Google Scholar
  38. 38.
    Billiau A, Heremans H, Vermeire K, Matthys P. Immunomodulatory properties of interferon-gamma. An update. Ann NY Acad Sci 1998; 856: 22–32.CrossRefGoogle Scholar
  39. 39.
    Laurat E, Poirier B, Tupin E, et al. In vivo downregulation of T helper cell 1 immune responses reduces atherogenesis in apolipoprotein Eknockout mice. Circulation 2001; 104: 197–202.PubMedCrossRefGoogle Scholar
  40. 40.
    Lio D, Licastro F, Scola L, et al. Interleukin-10 promoter polymorphism in sporadic Alzheimer’s disease. Genes Immun 2003; 4: 234–8.PubMedCrossRefGoogle Scholar
  41. 41.
    Deiana L, Pes GM, Carru C, et al. Lack of influence of apolipoprotein E4 on lipoprotein levels in the island population of Sardinia. Eur J Clin Invest 1998: 28: 290–4.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Internal Publishing Switzerland 2004

Authors and Affiliations

  • Giovanni Mario Pes
    • 1
  • Domenico Lio
    • 2
  • Ciriaco Carru
    • 1
  • Luca Deiana
    • 1
  • Giovannella Baggio
    • 3
  • Claudio Franceschi
    • 4
    • 5
  • Luigi Ferrucci
    • 5
  • Fabiola Oliveri
    • 5
  • Letizia Scola
    • 2
  • Antonio Crivello
    • 2
  • Giuseppina Candore
    • 2
  • Giuseppina Colonna-Romano
    • 2
  • Calogero Caruso
    • 2
  1. 1.Chair of Clinical BiochemistryUniversity of SassariSassari
  2. 2.Study Group on Immunosenescence, Department of Pathobiology and Biomedical MethodologiesUniversity of PalermoPalermo
  3. 3.Medicine UnitPadova HospitalPadovaItaly
  4. 4.Department of Experimental PathologyUniversity of BolognaBologna
  5. 5.Istituto Nazionale di Riposo e Cura per AnzianiAncona and FirenzeItaly

Personalised recommendations